Literature DB >> 25056550

Dynamic contrast-enhanced MR imaging of endometrial cancer: optimizing the imaging delay for tumour-myometrium contrast.

Sung Bin Park1, Min Hoan Moon, Chang Kyu Sung, Sohee Oh, Young Ho Lee.   

Abstract

PURPOSE: To investigate the optimal imaging delay time of dynamic contrast-enhanced magnetic resonance (MR) imaging in women with endometrial cancer.
MATERIALS AND METHODS: This prospective single-institution study was approved by the institutional review board, and informed consent was obtained from the participants. Thirty-five women (mean age, 54 years; age range, 29-66 years) underwent dynamic contrast-enhanced MR imaging with a temporal resolution of 25-40 seconds. The signal intensity difference ratios between the myometrium and endometrial cancer were analyzed to investigate the optimal imaging delay time using single change-point analysis.
RESULTS: The optimal imaging delay time for appropriate tumour-myometrium contrast ranged from 31.7 to 268.1 seconds. The median optimal imaging delay time was 91.3 seconds, with an interquartile range of 46.2 to 119.5 seconds. The median signal intensity difference ratios between the myometrium and endometrial cancer were 0.03, with an interquartile range of -0.01 to 0.06, on the pre-contrast MR imaging and 0.20, with an interquartile range of 0.15 to 0.25, on the post-contrast MR imaging.
CONCLUSION: An imaging delay of approximately 90 seconds after initiating contrast material injection may be optimal for obtaining appropriate tumour-myometrium contrast in women with endometrial cancer. KEY POINTS: • Recent advances have allowed for MR imaging of high temporal resolution. • Contrast-enhanced MR imaging is helpful for evaluation of endometrial cancer. • An imaging delay of 90 seconds may be optimal.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056550     DOI: 10.1007/s00330-014-3327-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  14 in total

Review 1.  MRI of malignant neoplasms of the uterine corpus and cervix.

Authors:  Evis Sala; Suzanne Wakely; Emma Senior; David Lomas
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

Review 2.  The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know.

Authors:  Evis Sala; Andrea G Rockall; Susan J Freeman; Donald G Mitchell; Caroline Reinhold
Journal:  Radiology       Date:  2013-03       Impact factor: 11.105

3.  Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases--a prospective randomized study in patients with chronic liver damage.

Authors:  Masayuki Kanematsu; Richard C Semelka; Masayuki Matsuo; Hiroshi Kondo; Mayumi Enya; Satoshi Goshima; Noriyuki Moriyama; Hiroaki Hoshi
Journal:  Radiology       Date:  2002-11       Impact factor: 11.105

Review 4.  The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.

Authors:  Evis Sala; Andrea Rockall; Deepa Rangarajan; Rahel A Kubik-Huch
Journal:  Eur J Radiol       Date:  2010-12       Impact factor: 3.528

5.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

6.  Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging.

Authors:  S Sironi; E Colombo; G Villa; G Taccagni; C Belloni; P Garancini; A DelMaschio
Journal:  Radiology       Date:  1992-10       Impact factor: 11.105

7.  Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.

Authors:  R C Boronow; C P Morrow; W T Creasman; P J Disaia; S G Silverberg; A Miller; J A Blessing
Journal:  Obstet Gynecol       Date:  1984-06       Impact factor: 7.661

8.  Paraaortic lymph node evaluation in stage I endometrial carcinoma.

Authors:  M S Piver; S B Lele; J J Barlow; L Blumenson
Journal:  Obstet Gynecol       Date:  1982-01       Impact factor: 7.661

9.  Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma.

Authors:  Evis Sala; Robin Crawford; Emma Senior; Ashley Shaw; Bryony Simcock; Kalliopi Vrotsou; Christopher Palmer; Pauline Rajan; Ilse Joubert; David Lomas
Journal:  Int J Gynecol Cancer       Date:  2009-01       Impact factor: 3.437

Review 10.  New MR techniques in gynecologic cancer.

Authors:  Jennie C Wakefield; Kate Downey; Stavroula Kyriazi; Nandita M deSouza
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

View more
  2 in total

Review 1.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

Review 2.  Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology.

Authors:  Stephanie Nougaret; Mariana Horta; Evis Sala; Yulia Lakhman; Isabelle Thomassin-Naggara; Aki Kido; Gabriele Masselli; Nishat Bharwani; Elizabeth Sadowski; Andrea Ertmer; Milagros Otero-Garcia; Rahel A Kubik-Huch; Teresa M Cunha; Andrea Rockall; Rosemarie Forstner
Journal:  Eur Radiol       Date:  2018-07-11       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.